Effective May 15, Japan's Ministry of Health, Labor and Welfare (MHLW) amended Japan's MRL regulation (link in Japanese). This update affects MRLs for the following active ingredients: alachlor, kresoxim-methyl, chromafenozide, saflufenacil, cyflumetofen, spiromesifen, trifluralin, fenbuconazole, flunixin, penthiopyrad, milbemectin, and metaflumizone.
Japan maintains an online MRL database, searchable by active ingredient. MRL updates typically take about a week to show up in the English-translated database; at this time, relevant changes will be made to www.mrldatabase.com.
